Distinguishing vesicular and pustular disorders in the neonate

Current Opinion in Pediatrics

Volumn 9, Issue 4, 1997, Pages 396-405

  Wagner, Annette ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLYLAMINE; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; COCAINE; CROMOGLYCATE DISODIUM; DAPSONE; IMIDAZOLE DERIVATIVE; KETOCONAZOLE; NARCOTIC AGENT; PERMETHRIN; STEROID; VARICELLA ZOSTER VACCINE;

ACNE; CANDIDIASIS; CHICKENPOX; CLINICAL FEATURE; CONGENITAL DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; ERYTHEMA; FEMALE; FOLLICULITIS; HERPES; HERPES SIMPLEX VIRUS; HUMAN; INCONTINENTIA PIGMENTI; INFLAMMATION; MALE; MASTOCYTOSIS; MELANOSIS; NEWBORN; NEWBORN DISEASE; NEWBORN INFECTION; NEWBORN PERIOD; PRIORITY JOURNAL; PUSTULE; PUSTULOSIS; REVIEW; SCABIES; SKIN MANIFESTATION; STAPHYLOCOCCUS INFECTION; SWEAT GLAND DISEASE; SYPHILIS;

EID: 0030823942     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199708000-00015     Document Type: Review

References (86)

1. Moisson YF, Wallach D: Pustular dermatoses in the neonatal period. Ann Pediatr 1992, 39:397.
2. Sahn EE: Vesiculopustular diseases of neonates and infants. Curr Opin Pediatr 1994, 6:442-446.
3. Platin P, Delaire PK, Gavanou J, et al.: Benign cutaneous lesions observed within the 1st 48 hours of life in 847 infants born at a maternity ward of a university hospital. Ann Dermatol Venereol 1990, 117:181.
4. Prigent F, Vige P, Marinet C: Cutaneous lesions during the 1st week of life in 306 consecutive newborn infants. Ann Dermatol Venereol 1991, 118:697.
5. Leung AC, Wheeler BH, Robson WL, et al.: Erythema toxicum present at birth. Pediatr Dermatol 1992, 9:162.
6. Oderam H, Bjorksten O, Leander E, et al.: Predictors of atopy in newborn babies. Allergy 1995, 50:585-592.
7. Laude TA: Approach to dermatologic disorders in black children. Semin Dermatol 1995, 14:15-20.
8. Ramamurthy RS, Reveri M, Esterty NB, et al.: Transient neonatal pustular melanosis. J Pediatr 1976, 88:330.
9. Ferrandez C, Coroleu LW, Ribera M, et al.: Sterile transient neonatal pustulosis is a precocious form of erythema toxicum neonatorum. Dermatology 1992, 185:18.
10. Hurwitz S: Cutaneous Disorders of the Newborn. In Clinical Pediatric Dermatology. Philadelphia: WB Saunders; 1993:12.
11. Arpey CJ, Nagashima-Whalen LS, Chren MM, et al.: Congenital miliaria crystalline: case report and literature review. Pediatr Dermatol 1992, 9:283.
12. Feng E, Janniger CK: Miliaria. Cutis 1995, 55:213-216.
13. Mowad CM, McGinley KJ, Foglia H, et al.: The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol 1995:729-733. Elegant demonstration of the role of S. epidermidis in miliaria.
14. Plewig G, Kligman AM: Acne in infancy. In Acne and Rosacea, edn 2. Berlin: Springer-Verlag; 1993.
15. Rapelanor R, Mortueux P, Couprie B, et al.: Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996, 132:190-193. Evidence for commensural yeast playing pathogenetic role in another common skin disorder.
16. Duarte AM, Kramer J, Yusk JW, et al.: Eosinophilic pustular folliculitis in infancy and childhood. Am J Dis Child 1993, 147:197.
17. Garcia-Patos V, Pujol RM, deMoragas JM: Infantile eosinophile pustular folliculitis. Dermatology 1994, 189:133-138.
18. Darmstadt GL, Tunnessen WW Jr, Swerer R: Eosinophilic pustular folliculitis. Pediatrics 1992, 89:1095.
19. Vicente J, Espana A, Idoate M, et al.: Are eosinophilic pustular folliculitis of infancy and infantile acropustulosis the same entity? Br J Dermatol 1996, 135:807-809. Interesting discussion of a possible common pathogenesis in these two idiopathic disorders.
20. Boone M, Dangorsse C, Andre J, et al.: Eosinophilic pustular folliculitis in three atopic children with hypersensitivity to Dermatophagoides pteronyssinus. Dermatology 1995, 190:164-168.
21. Dromy R, Raz A, Metzker A: Infantile acropustulosis. Pediatr Dermatol 1991, 8:284.
22. Laude TA: Skin disorders in black children. Curr Opin Pediatr 1996, 8:381-385. Excellent review of skin disorders in black children.
23. Dorton OW, Kaufman M: Palmoplantar pustules in an infant: acropustulosis of infancy. Arch Dermatol 1996, 132:1365-1366.
24. Nguyen J, Strobel M, Arnaud JP, et al.: Infantile acropustulosis: unusual manifestation of scabies in the infant? Ann Pediatr 1991, 38:479.
25. Prederville JS: Infantile acropustulosis: how often is it a sequela of scabies? Pediatr Dermatol 1995, 12:275-276.
26. Humaue S, Bureau B, Litoux P, et al.: Infantile acropustulosis in six immigrant children. Pediatr Dermatol 1995, 12:211-214.
27. Azana JM, Torrelo A, Mediero IG, Zambrano A: Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 1994, 11:102-106.
28. Leaf FA, Jaecks EP, Rodriguez Dr: Bullous urticaria pigmentosa. Cutis 1996, 58:358-360.
29. Cook J, Stith M, Sahn EE: Bullous mastocytosis in an infant associated with the use of a nonprescription cough suppressant. Pediatr Dermatol 1996, 13:410-414. Good discussion of pathogenesis and treatment of patients with urticaria pigmentosa.
30. Kettelhut BV, Metcalfe DD: Pediatric mastocytosis. Ann Allergy 1994, 73:197-202.
31. Van Gysel D, Oranje AP, Vermeiden I, de Lijster de Raadt J, Mulder PG, van Toorenenbergen AW: Value of urinary N-methylhistamine measurements in childhood mastocytosis. J Am Acad Dermatol 1996, 35:556-558. Discussion of urinary laboratory test that correlates with clinical disease severity.
32. Haas N, Hamann K, Grabbe J, Algermissen B, Czarnetzki BM: Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas. Arch Dermatol Res 1995, 287:242-248.
33. Hamann K, Haas N, Grabbe J, Czarnetzki BM: Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 1995, 133:203-208.
34. Lazarus GS: Mastocytosis: new understandings in cutaneous pathophysiology. J Dermatol 1996, 23:769-772. Excellent discussion of pathophysiology.
35. Landy SJ, Donnai D: Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet 1993, 30:53.
36. Yang JH, Ma SY, Tsai CH: Destructive encephalopathy in incontinentia pigmenti: a case report J Dermatol 1995, 22:340-343.
37. Lee AG, Goldberg MF, Gillard JH, Barker PB, Bryan RN: Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging. Arch Pediatr Adolesc Med 1995, 149:573-580.
38. Dutheil P, Vabres P, Cayla MC, Enjolras O: Incontinentia pigmenti: late sequelae and genotypic diagnosis: a three-generation study of four patients. Pediatr Dermatol 1995, 12:107-111. Good discussion of the use of DNA analysis in prenatal diagnosis.
39. Sahn EE, Davidson LS: Incontinentia pigmenti: three cases with unusual features. J Am Acad Dermatol 1994, 31:852-857.
40. Emery MM, Siegfried EC, Stone MS, Stone EM, Patil SR: Incontinentia pigmenti: transmission from father to daughter. J Am Acad Dermatol 1993, 29:368-372.
41. Kirchman TT, Levy ML, Lewis RA, Kanzler MH, Nelson DL, Scheuerle AE: Gonadal mosaicism for incontinentia pigmenti in a healthy male. J Med Genet 1995, 32:887-890. Good discussion of the concept of mosaicism and how it explains unusual presentations of this disease.
42. Gorski JL, Burright EN: The molecular genetics of incontinentia pigmenti. Semin Dermatol 1993, 12:255.
43. Pascual-Castroviejo J, Roche MC, Martinez Fernandez V, Perez-Romero M, Escudero RM, Garcia-Penas JJ, Sanchez M: Incontinentia pigmenti: MR demonstration of brain changes. Am J Neuroradiol 1994, 15:1521-1527.
44. Pollack S: Staphylococcal scalded skin syndrome. Pediatr Rev 1996, 17:18. Excellent clinical review of SSSS.
45. Yokota S, Imagawa T, Katakura S, Mitsuda T, Arai K: Staphylococcal scalded skin syndrome caused by exfoliative toxin B-producing methicillin-resistant Staphylococcus aureus. Eur J Pediatr 1996, 155:722.
46. Zafar AB, Butler RC, Reese DJ, Gaydos LA, Mennonna PA: Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995, 23:200-208.
47. Gemmell CG: Staphylococcal scalded skin syndrome. J Med Microbiol 1995, 43:318-327. Good discussion of our current understanding of the pathogenesis of this disease.
48. Peterson CM, Eichenfield LF: Scabies. Pediatr Ann 1996, 25:97-100. Excellent review of the clinical features and management of scabies.
49. Paller AS: Scabies in infants and small children. Semin Dermatol 1993, 12:3-8.
50. Talanin NY, Smith SS, Shelley ED, Moores WB: Cutaneous histocytosis with Langerhans cell features induced by scabies: a case report. Pediatr Dermatol 1994, 11:327-330.
51. Camassa F, Fania M, Ditano G, Silvestris AM, Lomuto M: Neonatal Scables. Cutis 1995, 56:210-212. Outbreak of Norwegian scabies is postulated to be caused by chronic application of topical steroids.
52. Brown S, Becher J, Brady W: Treatment of ectoparasitic infections: review of the English-Language literature, 1982-1992. Clin Infect Dis 1995, Suppl 1:S104-S109.
53. Gibney MD, Siegfried EC: Cutaneous congenital candidiasis: a case report. Pediatr Dermatol 1995, 12:359-363. Case report of cutaneous congenital candidiasis with excellent discussion of pathogenesis, clinical presentation, and treatment.
54. Lane AT: Cutaneous candidiasis. Pediatr Dermatol 1995, 12:369.
55. Raval DS, Barton LL, Hansen RC, Kling PJ: Congenital cutaneous candidiasis: case report and review. Pediatr Dermatol 1995, 12:355-358.
56. Jin Y, Endo A, Shimada M, Minato M, Takada M, Takahashi S, Harada K: Congenital systemic candidiasis. Pediatr Infect Dis J 1995, 14:818-820.
57. Faix RG, Kovarik SM, Shaw TR, et al.: Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 1989, 83:101.
58. McDonnell M, Isaacs D: Neonatal systemic candidiasis. J Paediatr Child Health 1995, 31:490-492.
59. Rabalais GP, Samiec TD, Bryant KK, Lewis JJ: Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J 1996, 15:348-352. Retrospective review of infants weighing more than 2500 g with systemic candidal infection. Those infants with major congenital anomalies were at greatest risk for sepsis.
60. Khatib R, Clark JA, Briski LE, Wilson Fm: Relevance of culturing Candida species from intravascular catheters. J Clin Microbiol 1995, 33:1635-1637.
61. Goldstein SM: Advances in the treatment of superficial candida infections. Semin Dermatol 1993, 12:315-330.
62. Elewski BE: Cutaneous mycoses in children. Br J of Dermatol 1996, 46:7-11. Excellent review of cutaneous fungal infections in children, with emphasis on new topical and systemic therapies.
63. van den Anker JN, van Popele NM, Sauer PJ: Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother 1995, 39:1391-1397.
64. Bennet ML, Lynn AW, Klein LE, Balkowiec KS: Congenital syphilis: subtle presentation of fulminant disease. J Am Acad Dermatol 1997, 36:351-354. Good discussion of factors contributing to increased incidence of congenital syphilis, cutaneous manifestations, problems in serodiagnosis, and management.
65. Sisson CG, Ostrea EM Jr, Reyes MP, Salari V: The resurgence of congenital syphilis: a cocaine-related problem. J Pediatr 1997, 130:289-292. A high incidence of congenital syphilis is seen in cocaine-using mothers.
66. McFarlin BL, Bottoms SF: Maternal syphilis: the next pregnancy. Am J Perinatol 1996, 13:513-518.
67. Glaser JH: Centers for Disease Control and Prevention guidelines for congenital syphilis. J Pediatr 1996, 1229:488-490.
68. Risser WL, Hwang LY: Problems in the current case definitions of congenital syphilis. J Pediatr 1996, 129:499-505.
69. Beeram MR, Chopde N, Dawood Y, Siriboe S, Abedin M: Lumbar puncture in the evaluation of possible asymptomatic congenital syphilis in neonates. J Pediatr 1996, 128:125-129.
70. Jenkins M, Kohl S: New aspects of neonatal herpes. Infect Dis Clin North Am 1992, 6:57.
71. Whitley RJ: Neonatal herpes simplex infections: pathogenesis and therapy. Pathol Biol 1992, 40:729.
72. Elder DE, Minutillo C, Pemberton PJ: Neonatal herpes simplex infection: keys to early diagnosis. J Paediatr Child Health 1995, 31:307-311.
73. Malm G, Berg U, Forsgren M: Neonatal herpes simplex: clinical findings and outcome in relation to type of maternal infection. Acta Paediatr 1995, 84:256-260.
74. Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, Jacobs R, Van Dyke R, Burchett S, Soong SJ, et al.: Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996, 15:247-254. Results of a phase II trial of oral acyclovir for prevention of recurrences of skin, eyes, mouth HSV.
75. Kimberlin DW, Lakeman FD, Arvin AM, Prober CG, Corey L, Powell DA, Burchett SK, Jacobs RF, Starr SE, Whitley RJ: Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1996, 174:1162-1167. Use of polymerase chain reaction to detect viral DNA in cerebrospinal fluid after treatment. Correlation of positive results with poor outcome of neonate.
76. Randolph AG, Hartshorn RM, Washington AE: Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis. Obstet Gynecol 1996, 88:603-610.
77. O'Reilly MA, O'Reilly PM, de Bruyn R: Neonatal herpes simplex type 2 encephalitis: its appearances on ultrasound and CT. Pediatric Radiology 1995, 25:68-69.
78. Bravo FJ, Bourne N, Harrison CJ, Mani C, Stanberry LR, Myers MG, Bernstein DI: Effect of antibody alone and combined with acyclovir on neonatal herpes simplex virus infection in guinea pigs. J Infect Dis 1996, 173:1-6.
79. Carmack MA, Prober CG: Neonatal herpes: vexing dilemmas and reasons for hope. Curr Opin Pediatr 1993, 5:21.
80. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M: Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994, 343:1548-1551.
81. Katz VL, Kuller JA, McMahon MJ, Warren MA, Wells SR: Varicella during pregnancy: maternal and fetal effects. Western J Med 1995, 163:446-450.
82. Wang EEL, Prober CG, Arvin AM: Varicella-zoster virus antibody titers before and after administration of zoster immune globulin to neonates in an intensive care nursery. J Pediatr 1983, 103:113.
83. American Academy of Pediatrics: Varicella-zoster infections. In 1997 Red Book: Report of the Committee on Infectious Diseases 24th ed. Elk Grove Village, IL; American Academy of Pediatrics; 1997:573-585.
84. Gershon AA: More questions about varicella vaccination. Pediatr Infect Dis J 1996, 15:560-561.
85. Fairley CK, Miller E: Varicella-zoster virus epidemiology: a changing scene? J Infect Dis 1996, suppl 3:S314-S319. Discussion of the increased incidence of varicella and complications of this disease in childhood. The role of varicella vaccine in reducing risk is discussed.
86. Kan BD, Ault MJ, Greenspoon JS: Varicella vaccine and susceptible pregnant mothers. Pediatrics 1996, 97:441.